Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity
Key facts
- Who runs it
- Atlantic Health System
- Where
- Morristown, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 2 Jan 2025
- Expected to end
- 2 May 2027
- Type of study
- Observational
- Treatments tested
- Pressure volume loop evaluation
- cardiovascular magnetic resonance imaging
- Cardiopulmonary exercise testing (CPET)
- Kansas City Cardiomyopathy Questionairre
- Record updated
- 17 December 2024
Who can take part
- Age
- 18 years and older
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age >=18 years of age
- Able to give informed consent
- Primary (degenerative) mitral regurgitation
- LVEF >=50%
- Undergoing cardiac catheterization
- Able to exercise on a treadmill
Who cannot take part
- LVEF <50%
- Unable to give informed consent
- Secondary (functional) mitral regurgitation
- Known coronary artery stenosis >=70% or past revascularization
- More than mild aortic stenosis, mitral stenosis, aortic regurgitation, tricuspid regurgitation, or pulmonic regurgitation
- Hypertrophic cardiomyopathy
- Pregnancy
Where in United States
- Morristown Medical CenterMorristown, United StatesContact: Kush Murkerjee, MATaking people
About the trial
What the trial wants to find out
The current American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend surgery in patient with mitral regurgitation (MR) based on 1) the severity of MR and 2) the presence or absence of symptoms. Studies have shown that Cardiovascular Magnetic Resonance (CMR) is an accurate method to quantify the severity of MR. However, studies have also shown that symptoms are not necessarily related to the presence of symptoms. Thus, there appears to be a disconnect between the severity of MR and symptoms. Recent analysis of our data has shown that females and older patients with smaller ventricles, lower stroke volumes, and lower regurgitant volume relative to regurgitant fraction tend to be symptomatic. These findings suggest that decreased left ventricular compliance, i.e. diastolic dysfunction, may play an important role as an etiology of symptoms in patients with mitral regurgitation. The aim of this study is to study the presence of diastolic dysfunction in patients with MR and its association with symptom burden and exercise capacity.
The group in the trial
- Mitral Regurgitation
Patients with mitral regurgitation undergoing a left heart catheterization prior to mitral valve surgery or mitral valve clip.
Treatment: Pressure volume loop evaluation, cardiovascular magnetic resonance imaging, Cardiopulmonary exercise testing (CPET), and Kansas City Cardiomyopathy Questionairre
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessing the Impact of Diastolic Dysfunction on the Presence of Symptoms in Patients with Primary Mitral Regurgitation.
- Record updated
- 17 December 2024